alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service 

# AGENCY:

Internal Revenue Service (IRS) Treasury. 

# ACTION:

Notice of Meeting.

# SUMMARY:

                        An open meeting of the Taxpayer Advocacy Panel Earned                               ( print page 52726)                            Income Tax Credit Issue Committee will be conducted via telephone conference call. The Taxpayer Advocacy Panel is soliciting public comments, ideas and suggestions on improving customer service at the Internal Revenue Service.                     

# DATES:

The meeting will be held Wednesday, October 8, 2008. 

# FOR FURTHER INFORMATION CONTACT:

Audrey Y. Jenkins at 1-888-912-1227 or 718-488-2085. 

# SUPPLEMENTARY INFORMATION:

                    Notice is hereby given pursuant to Section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Taxpayer Advocacy Panel Earned Income Tax Credit Issue Committee will be held Wednesday, October 8, 2008, from 1 to 2 p.m. Eastern Time via a telephone conference call. The public is invited to make oral comments. Individual comments will be limited to 5 minutes. For information or to confirm attendance, notification of intent to attend the meeting must be made with Audrey Y. Jenkins. Ms. Jenkins may be reached at 1-888-912-1227 or (718) 488-2085. Send written comments to Audrey Y. Jenkins, TAP Office, 10 MetroTech Center, 625 Fulton Street, Brooklyn, NY 11201 or post comments to the Web site:                     *http://www.improveirs.org*. Due to limited conference lines, notification of intent to participate in the telephone conference call meeting must be made in advance.                 

The agenda will include various IRS issues. 

Dated: August 29, 2008. 

Roy L. Block, 

Acting Director, Taxpayer Advocacy Panel.

[FR Doc. E8-20941 Filed 9-9-08; 8:45 am] 

BILLING CODE 4830-01-P
Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk July 28, 2009

d0721 

# Order

July 28, 2009

137967

KELLY SUE SYMONS, Personal Representative of the Estate of DANIEL A. SYMONS, Plaintiff-Appellee,

v SC: 137967 COA: 269663 Calhoun CC: 04-000769-NH DR. ROBERT J. PRODINGER, Defendant-Appellee,

and

DALE RUSSELL, P.A., and BATTLE CREEK EMERGENCY ROOM PHYSICIANS, P.C., Defendants-Appellants,

and

BATTLE CREEK HEALTH SYSTEMS, Defendant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal the November 13, 2008 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented s hould be reviewed by this Court.
Exhibit 10.10



 






Exhibit 10.10




Bonus Plan For Senior Managers




Plan Summary



Certain of the Company’s senior management employees, including the Company’s named executive
officers, are eligible to participate in a cash bonus plan for senior managers (the “Plan”). Such
employees are eligible to receive a discretionary cash bonus on an annual basis in an amount up to
a specified percentage of the employee’s base salary. The amount of the discretionary bonus is
determined based on the achievement of targets by the Company related to sales growth, improvement
in earnings before interest and taxes, and reduction of expenses as a percentage of sales.



Each employee that participates in the Plan must work through a specified date to be eligible for
payment under the Plan. Bonus payments, if any, typically occur in the first quarter of the next
calendar year after the completion of the audit for the prior fiscal year.
#### The People of the State of New York, Respondent, v Anthony A. Chiarenza, Appellant.

Judgment unanimously reversed on the law and new trial granted. Memorandum: On appeal from a judgment convicting him of criminal sale of a controlled substance in the first degree *(see,*Penal Law § 220.43 [1]) and criminal possession of a controlled substance in the first degree *(see,*Penal Law § 220.21 [1]), defendant contends that the suppression court committed reversible error when it conducted pretrial hearings in his absence. We agree.

It is well established that a defendant has a statutory and constitutional right to be present at all critical stages of trial whenever his presence has a relation, reasonably substantial, to the fullness of his opportunity to defend against the charge (US Const 6th Amend; NY Const, art I, § 6; CPL 340.50 [1]; 260.20; *Snyder v Massachusetts,*291 US 97, 105-106; *People v Ciaccio,*47 NY2d 431, 436). The definition of "trial” encompasses pretrial hearings on motions to suppress evidence *(People v Anderson,*16 NY2d 282, 286-287; *People v Gaines,*144 AD2d 941). Although a defendant may waive the right to be present *(Diaz v United States,*223 US 442; *People v Byrnes,*33 NY2d 343), such waiver "must be tested according to constitutional standards” *(People v Parker,*57 NY2d 136, 140). Thus, the issue is whether "defendant knowingly, voluntarily and intelligently relinquished his known right” *(People v Parker, supra,*at 140). "A defendant must be informed in some manner of the nature of his right to be present and the consequences of a failure to appear” *(People v Gaines, supra,*at 941).

Here, the record does not reflect that defendant was informed of the date of the pretrial hearings. Further, there has been no showing that the court apprised him of the nature of his right to be present or the consequences of his failure to exercise that right. Upon being informed by defense counsel that defendant was "not coming”, the court summarily "dis*901pense[d] with the appearance of’ defendant. Thus, the record is clearly insufficient to support a finding that defendant knowingly, voluntarily and intelligently waived his right to be present at the pretrial hearings.

In view of our determination, we do not address defendant’s remaining contentions. (Appeal from judgment of Ontario County Court, Reed, J.—criminal sale of controlled substance, first degree.) Present—Callahan, J. P., Doerr, Denman, Law-ton and Davis, JJ.
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                             SEP-30-1999
<PERIOD-START>                                OCT-01-1999
<PERIOD-END>                                  JUN-30-1999
<CASH>                                             62,775
<SECURITIES>                                            0
<RECEIVABLES>                                     382,744
<ALLOWANCES>                                       11,184
<INVENTORY>                                       456,809
<CURRENT-ASSETS>                                  918,603
<PP&E>                                          2,568,495
<DEPRECIATION>                                  2,306,083
<TOTAL-ASSETS>                                  1,226,180
<CURRENT-LIABILITIES>                             471,774
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                           91,003
<OTHER-SE>                                        334,307
<TOTAL-LIABILITY-AND-EQUITY>                    1,226,180
<SALES>                                         2,354,715
<TOTAL-REVENUES>                                2,354,715
<CGS>                                           2,310,908
<TOTAL-COSTS>                                   2,630,044
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  7,564
<INCOME-PRETAX>                                  (282,893)
<INCOME-TAX>                                          225
<INCOME-CONTINUING>                                     0
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                     (283,118)
<EPS-BASIC>                                       (0.31)
<EPS-DILUTED>                                           0



</TABLE>
I 

117TH CONGRESS 

2D SESSION H. R. 6835 

To withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the Russian 

Federation. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 25, 2022 

Mr. DOGGETT (for himself, Mr. BLUMENAUER, Mrs. MURPHY of Florida, Mr. 

PASCRELL, Ms. SCHAKOWSKY, Ms. KAPTUR, Ms. GARCIA of Texas, Mr. 

LEVIN of Michigan, Mr. EVANS, and Ms. NEWMAN) introduced the following bill; which was referred to the Committee on Ways and Means, 

and in addition to the Committee on Foreign Affairs, for a period to be 

subsequently determined by the Speaker, in each case for consideration 

of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To withdraw normal trade relations treatment from, and 

apply certain provisions of title IV of the Trade Act 

of 1974 to, products of the Russian Federation. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be known as the ‘‘No Most Favored 

5 Nation Trading with Russia Act’’. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 6835 IH

1 SEC. 2. WITHDRAWAL OF NORMAL TRADE RELATIONS 

2 TREATMENT WITH THE RUSSIAN FEDERA3 TION. 

4 Notwithstanding the provisions of title I of the Russia 

5 and Moldova Jackson-Vanik Repeal and Sergei Magnitsky 

6 Rule of Law Accountability Act of 2012 (Public Law 112– 

7 208; 19 U.S.C. 2434 note) or any other provision of law, 

8 effective on the date of the enactment of this Act— 

9 (1) normal trade relations treatment shall not 

10 apply pursuant to section 102 of that Act to the 

11 products of the Russian Federation; and 

12 (2) normal trade relations treatment may there13 after be extended to the products of the Russian 

14 Federation only in accordance with the provisions of 

15 chapter 1 of title IV of the Trade Act of 1974 (19 

16 U.S.C. 2431 et seq.), as in effect with respect to the 

17 products of the Russian Federation on the day be18 fore the effective date of the accession of the Rus19 sian Federation to the World Trade Organization. 

20 SEC. 3. COOPERATION WITH UNITED STATES ALLIES AND 

21 PARTNERS. 

22 (a) IN GENERAL.—The President shall encourage al23 lies and partners of the United States— 

24 (1) to consider taking similar actions such as 

25 the withdrawal of permanent normal trade relations 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 6835 IH

1 treatment for products of the Russian Federation; 

2 and 

3 (2) to condemn the Russian Federation’s recent 

4 aggression in Ukraine at the World Trade Organiza5 tion (WTO). 

6 (b) ACCOUNTABILITY AT THE WTO.—The President 

7 shall direct the U.S. Permanent Mission to the World 

8 Trade Organization to use the voice, vote, and influence 

9 of the United States at the WTO to seek the suspension 

10 of the Russian Federation’s membership in the WTO. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6815 Introduced in House (IH)]

<DOC>

117th CONGRESS
  2d Session
                                H. R. 6815

To amend title 18, United States Code, to limit the ability to assess a 
  fee for health care services for prisoners, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 22, 2022

  Ms. Norton introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend title 18, United States Code, to limit the ability to assess a 
  fee for health care services for prisoners, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Federal Bureau of Prisons Medical 
Care Act of 2022''.

SEC. 2. NO FEE FOR HEALTH CARE SERVICES FOR PRISONERS.

    Section 4048 of title 18, United States Code, is amended--
            (1) by amending subsection (b) to read as follows:
    ``(b) Fees for Health Care Services.--In the case of health care 
services provided to a prisoner in connection with a health care visit 
that results from an injury inflicted on a prisoner by another 
prisoner, the Director, in accordance with this section and with such 
regulations as the Director shall promulgate to carry out this section, 
may assess and collect a fee in connection with each such health care 
visit, from the account of the prisoner who inflicted the injury, as 
determined by the Director.'';
            (2) by striking subsection (c); and
            (3) in subsection (e), by striking ``or whether the 
        prisoner qualifies under an exclusion under this section''.
                                 <all>
```
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

In connection with the Quarterly Report on Form 10-Q of Precision Castparts Corp. (the Company) for the fiscal quarter ended July 1, 2007 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I, William D. Larsson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                 
|-------------------------------------------------
|Date: August 10, 2007                            
|                                                 
|/s/ William D. Larsson                           
|William D. Larsson                               
|Senior Vice President and Chief Financial Officer
Exhibit 10.2



Exhibit 10.2


BRITISH COLUMBIA

Ministry of Employment and Investment

Energy and Minerals Division

Minerals Titles Branch



Minerals Tenure Act

Section 52


BILL OF SALE ABSOLUTE


	
INDICATE TYPE OF SALE:
	
MINERAL

	 
	
MINING DIVISION:
	
CARIBOU





SELLER


I, Glengarry Development Corp. 1102-1010 Howe Street, Vancouver, British Columbia V6V 1P5, (604) 209-6565 - Client Number 145065


PURCHASE


Woodburn Holdings Ltd. 885 Pyrford Road, West Vancouver, British Columbia V7V 2A2 (604) 925-0220.


For and in consideration of the sum of Eight Thousand Five Hundred US ($8,500.00) paid to me. Do hereby sell the interest as specified below in the following mineral title:


	 	
Tenure 
	 
	
Claim Name of Lease Type
	
Number
	
Percentage of title being sold

	 
	
K9
	
406361
	
100%






I declare that I have good title to these tenures and every right to sell the same, in witness whereof have today signed my legal name.


	
/s/ Glengarry D
	
/s/ R. M. Baker

	
Glengarry Development Corp.
	
Woodburn Holdings Ltd.





 

Dated:   December 10, 2004
| 001-11001                                | 06-0619596                        |
|------------------------------------------|-----------------------------------|
| (Commission File Number)                 | (IRS Employer Identification No.) |
|                                     |                              |
| 3 High Ridge Park, Stamford, Connecticut | 06905                             |
| (Address of principal executive offices) | (Zip Code)                        |

|   | x | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|--------|---|---------------------------------------------------------------------------------------|

|   | o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|--------|---|----------------------------------------------------------------------------------------|

|   | o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|--------|---|--------------------------------------------------------------------------------------------------------|

|   | o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c)) |
|--------|---|-------------------------------------------------------------------------------------------------------|

----

| Item 8.01 | Other Events |
|-----------|--------------|

| Item 9.01 | Financial Statements and Exhibits |
|-----------|-----------------------------------|

|   | 99.1 | Press Release of Frontier Communications Corporation released on June 4, 2010. |
|--------|------|--------------------------------------------------------------------------------|

----

|                          | FRONTIER COMMUNICATIONS CORPORATION |
|-------------------------------|-------------------------------------|
|                          |                                |
| Date:  June 4, 2010 | By:/s/ Robert J. Larson             |
|                          | Robert J. Larson                    |
|                          | Senior Vice President and           |
|                          | Chief Accounting Officer            |
|                          |                                |
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 20-1203V

UNPUBLISHED

KYRIAN J. MARSHALL,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: December 22, 2021

Special Processing Unit (SPU);

Ruling on Entitlement; Concession;

Table Injury; Influenza (Flu); 

Shoulder Injury Related to Vaccine 

Administration (SIRVA).

Kathy Ann Lee, Christie Farrell Lee & Bell, P.C., Indianapolis, IN, for Petitioner.

Zoe Wade, U.S. Department of Justice, Washington, DC, for Respondent.

RULING ON ENTITLEMENT1

On September 15, 2020, Kyrian J. Marshall filed a petition for compensation under 

the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.

2

(the 

“Vaccine Act”). Petitioner alleged that she suffered a shoulder injury related to vaccine 

administration (“SIRVA”) as a result of the influenza (“flu”) vaccine administered on 

October 17, 2017. Petition at 1. The case was assigned to the Special Processing Unit of 

the Office of Special Masters. 

On December 21, 2021, Respondent filed his Rule 4(c) report in which he

concedes that Petitioner’s alleged injury is consistent with SIRVA as defined by the 

Vaccine Injury Table, and that compensation is appropriate. Specifically, Petitioner had 

no recent history of pain, inflammation, or dysfunction of her right shoulder; the onset of 

1 Because this unpublished opinion contains a reasoned explanation for the action in this case, I am 

required to post it on the United States Court of Federal Claims' website in accordance with the EGovernment Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic 

Government Services). This means the opinion will be available to anyone with access to the internet.

In accordance with Vaccine Rule 18(b), Petitioners have 14 days to identify and move to redact medical or 

other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon 

review, I agree that the identified material fits within this definition, I will redact such material from public 

access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease 

of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2012).
2

Petitioner’s pain occurred within 48 hours after receipt of an intramuscular vaccination; 

Petitioner’s pain was limited to the shoulder in which the vaccine was administered; and 

no other condition or abnormality has been identified to explain Petitioner’s right shoulder 

symptoms. Respondent further agrees that Petitioner met the statutory requirements by 

suffering the condition for more than six months. Rule 4(c) Report (ECF No. 30) at 1, 7-8

(citing 42 C.F.R. §§ 100.3(a), (c)(10)).

In view of Respondent’s position and the evidence of record, I find that 

Petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master